Overview
Kohsaku Numa practices in Kyoto, Japan. Numa is rated as an Advanced expert by MediFind in the treatment of Fuchs Dystrophy. Their top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Familial Hypertriglyceridemia, and Vitrectomy.
Their clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Fuchs Dystrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Fuchs DystrophyNuma isAdvanced. Learn about Fuchs Dystrophy.
- Experienced
- Familial Hypertriglyceridemia
- Macular Corneal Dystrophy Type 1
- VitrectomyNuma isExperienced. Learn about Vitrectomy.